We also found that LINC00152 promotes CRC proliferation, metastasis, and chemoresistance by binding with miR‐139‐5p,10 whereas UCA1 promotes CRC proliferation and chemotherapy resistance by inhibiting miR‐204‐5p.11 Here, UCA1 is linked to colorectal carcinoma.